BanColombia S.A. And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – BanColombia S.A. (CIB), Camtek Ltd. (CAMT), Amgen (AMGN) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. BanColombia S.A. (CIB)

56.1% sales growth and 15.73% return on equity

Bancolombia S. A. provides various banking products and services to individual and corporate customers in Colombia, Panama, Puerto Rico, El Salvador, Costa Rica, and Guatemala. The company operates through nine segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking, and All Other. It offers checking and savings accounts, fixed term deposits, and investment products; trade financing, loans funded by domestic development banks, working capital loans, credit cards, personal and vehicle loans, payroll loans, and overdrafts; financial support to real estate developers and mortgages for individuals and companies; and financial and operating leasing services. The company also provides hedging instruments, including futures, forwards, options, and swaps; and brokerage, investment advisory, and private banking services, including selling and distributing equities, futures, foreign currencies, fixed income securities, mutual funds, and structured products. In addition, it offers cash management services; foreign currency transaction services; life, auto, commercial, and homeowner's insurance products; and online and computer banking services. Further, the company provides investment banking services comprising project and acquisition finance, debt and equity capital markets, principal investments, M&A, restructurings, and structured financing; money market accounts, mutual and pension funds, private equity funds, payment trust, custody, and corporate trust; and digital banking platform, transportation, securities brokerage, maintenance and remodeling, advertising and marketing, and outsourcing services, as well as credit cards. As of December 31, 2020, it operated 1,057 branches; 18,631 banking correspondents; 535 PAMs; 215 kiosks in El Salvador and 137 in Colombia; and 6,124 automatic teller machines. Bancolombia S.A. was incorporated in 1945 and is headquartered in Medellín, Colombia.

Earnings Per Share

As for profitability, BanColombia S.A. has a trailing twelve months EPS of $6.41.

PE Ratio

BanColombia S.A. has a trailing twelve months price to earnings ratio of 5.04. Meaning, the purchaser of the share is investing $5.04 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.73%.

2. Camtek Ltd. (CAMT)

30.1% sales growth and 18.28% return on equity

Camtek Ltd., together with its subsidiaries, develops, manufactures, and sells inspection and metrology equipment for the advanced interconnect packaging, memory, complementary metal oxide semiconductor image sensors, micro-electro mechanical systems, radio frequency, and other segments of the semiconductor industry. It provides inspection and metrology systems, including Eagle-i, a system that delivers 2D inspection and metrology capabilities; Eagle-AP, which addresses the advanced packaging market using software and hardware technologies that deliver superior 2D and 3D inspection and metrology capabilities on the same platform; and Golden Eagle, a panel inspection and metrology system to support fanout wafer level packaging applications. The company sells its products in the Asia Pacific, the United States, and Europe. Camtek Ltd. was incorporated in 1987 and is headquartered in Migdal HaEmek, Israel.

Earnings Per Share

As for profitability, Camtek Ltd. has a trailing twelve months EPS of $1.63.

PE Ratio

Camtek Ltd. has a trailing twelve months price to earnings ratio of 51.22. Meaning, the purchaser of the share is investing $51.22 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.28%.

Yearly Top and Bottom Value

Camtek Ltd.’s stock is valued at $83.48 at 20:22 EST, under its 52-week high of $89.65 and way above its 52-week low of $24.81.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 35.7% and 28.9%, respectively.

3. Amgen (AMGN)

19.1% sales growth and 135.79% return on equity

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Earnings Per Share

As for profitability, Amgen has a trailing twelve months EPS of $12.48.

PE Ratio

Amgen has a trailing twelve months price to earnings ratio of 22.78. Meaning, the purchaser of the share is investing $22.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 135.79%.

Sales Growth

Amgen’s sales growth is 23.6% for the present quarter and 19.1% for the next.

Volume

Today’s last reported volume for Amgen is 2121860 which is 30.03% below its average volume of 3032720.

4. Middlesex Water Company (MSEX)

14.5% sales growth and 7.62% return on equity

Middlesex Water Company owns and operates regulated water utility and wastewater systems. It operates in two segments, Regulated and Non-Regulated. The Regulated segment collects, treats, and distributes water on a retail and wholesale basis to residential, commercial, industrial, and fire protection customers in parts of New Jersey, Delaware, and Pennsylvania. This segment also includes regulated wastewater systems in New Jersey and Delaware. The Non-Regulated segment provides non-regulated contract services for the operation and maintenance of municipal and private water and wastewater systems in New Jersey and Delaware. The company was incorporated in 1896 and is headquartered in Iselin, New Jersey.

Earnings Per Share

As for profitability, Middlesex Water Company has a trailing twelve months EPS of $1.76.

PE Ratio

Middlesex Water Company has a trailing twelve months price to earnings ratio of 28.97. Meaning, the purchaser of the share is investing $28.97 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.62%.

Yearly Top and Bottom Value

Middlesex Water Company’s stock is valued at $50.98 at 20:22 EST, way under its 52-week high of $84.38 and above its 52-week low of $48.59.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Feb 14, 2024, the estimated forward annual dividend rate is 1.3 and the estimated forward annual dividend yield is 2.55%.

Sales Growth

Middlesex Water Company’s sales growth is 16.8% for the ongoing quarter and 14.5% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 39.4% and 12.7%, respectively.

5. Arista Networks (ANET)

10.9% sales growth and 34.49% return on equity

Arista Networks, Inc. engages in the development, marketing, and sale of data-driven, client to cloud networking solutions for data center, campus, and routing environments in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. Its cloud networking solutions consist of Extensible Operating System (EOS), a publish-subscribe state-sharing networking operating system offered in combination with a set of network applications. The company offers data center and cloud networking systems, including newer artificial intelligence (AI) ethernet switching platforms; campus wired and wireless products, and routing systems addressing Core Routing, Edge Routing, Data Center Interconnect (DCI), Multi-cloud and Wide Area Networking (WAN) use cases; and a suite of value-add software solutions that leverage EOS to provide end-to-end orchestration, automation, analytics, network monitoring, and security. It also provides post contract customer support services, such as technical support, hardware repair and replacement parts beyond standard warranty, bug fixes, patches, and upgrade services. The company serves a range of industries comprising internet companies, service providers, financial services organizations, government agencies, media and entertainment companies, telecommunication service providers, and others. It markets and sells its products through distributors, system integrators, value-added resellers, and original equipment manufacturer partners, as well as through its direct sales force. The company was formerly known as Arastra, Inc. and changed its name to Arista Networks, Inc. in October 2008. Arista Networks, Inc. was incorporated in 2004 and is headquartered in Santa Clara, California.

Earnings Per Share

As for profitability, Arista Networks has a trailing twelve months EPS of $6.58.

PE Ratio

Arista Networks has a trailing twelve months price to earnings ratio of 44.07. Meaning, the purchaser of the share is investing $44.07 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.49%.

Volume

Today’s last reported volume for Arista Networks is 1364390 which is 44.99% below its average volume of 2480680.

Revenue Growth

Year-on-year quarterly revenue growth grew by 20.8%, now sitting on 5.86B for the twelve trailing months.

Previous days news about Arista Networks(ANET)

  • According to Zacks on Thursday, 28 March, "Some other top-ranked stocks from the broader technology sector are BlackLine (BL Quick QuoteBL – Free Report) , Arista Networks (ANET Quick QuoteANET – Free Report) and Dell Technologies (DELL Quick QuoteDELL – Free Report) , each carrying a Zacks Rank #2 at present. "
  • Arista networks (anet) laps the stock market: here's why. According to Zacks on Thursday, 28 March, "The upcoming earnings release of Arista Networks will be of great interest to investors. ", "In that report, analysts expect Arista Networks to post earnings of $1.71 per share. "

6. Consolidated Edison (ED)

7.2% sales growth and 11.97% return on equity

Consolidated Edison, Inc., through its subsidiaries, engages in the regulated electric, gas, and steam delivery businesses in the United States. It offers electric services to approximately 3.7 million customers in New York City and Westchester County; gas to approximately 1.1 million customers in Manhattan, the Bronx, parts of Queens, and Westchester County; and steam to approximately 1,530 customers in parts of Manhattan. The company also supplies electricity to approximately 0.3 million customers in southeastern New York and northern New Jersey; and gas to approximately 0.2 million customers in southeastern New York. In addition, it operates 545 circuit miles of transmission lines; 15 transmission substations; 63 distribution substations; 90,051 in-service line transformers; 3,788 pole miles of overhead distribution lines; and 2,314 miles of underground distribution lines, as well as 4,363 miles of mains and 380,870 service lines for natural gas distribution. Further, the company invests in electric and gas transmission projects. It primarily sells electricity to industrial, commercial, residential, and government customers. Consolidated Edison, Inc. was founded in 1823 and is based in New York, New York.

Earnings Per Share

As for profitability, Consolidated Edison has a trailing twelve months EPS of $7.21.

PE Ratio

Consolidated Edison has a trailing twelve months price to earnings ratio of 12.6. Meaning, the purchaser of the share is investing $12.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.

Volume

Today’s last reported volume for Consolidated Edison is 1628440 which is 8.47% below its average volume of 1779310.

7. National Oilwell Varco (NOV)

7% sales growth and 17.32% return on equity

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors worldwide. The company operates through three segments: Wellbore Technologies, Completion & Production Solutions, and Rig Technologies. It provides solids control and waste management equipment and services; portable power generation products; drill and wired pipes; drilling optimization and automation services; tubular inspection, repair, and coating services; instrumentation; measuring and monitoring services; downhole and fishing tools; steerable technologies; and drill bits. The company also offers equipment and technologies for hydraulic fracture stimulation, including downhole multistage fracturing tools, pressure pumping trucks, blenders, sanders, hydration and injection units, flowline, and manifolds; coiled tubing units, and wireline units and tools; connections and liner hangers; onshore production consists of composite pipe, surface transfer and progressive cavity pumps, and artificial lift systems; and offshore production, such as floating production systems and subsea production technologies, as well as manufactures industrial pumps and mixers. In addition, it provides substructures, derricks, and masts; cranes; jacking systems; pipe lifting, racking, rotating, and assembly systems; mud pumps; pressure control equipment; drives and generators; rig instrumentation and control systems; mooring, anchor, and deck handling machinery; equipment components for offshore wind construction vessels; and pipelay and construction systems. Further, the company offers spare parts, repair, and rentals as well as comprehensive remote equipment monitoring, technical support, field service, and customer training. The company was formerly known as National Oilwell Varco, Inc. and changed its name to NOV Inc. in January 2021. NOV Inc. was founded in 1862 and is based in Houston, Texas.

Earnings Per Share

As for profitability, National Oilwell Varco has a trailing twelve months EPS of $2.5.

PE Ratio

National Oilwell Varco has a trailing twelve months price to earnings ratio of 7.51. Meaning, the purchaser of the share is investing $7.51 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.32%.

Sales Growth

National Oilwell Varco’s sales growth is 7.9% for the present quarter and 7% for the next.

Yearly Top and Bottom Value

National Oilwell Varco’s stock is valued at $18.76 at 20:22 EST, way below its 52-week high of $21.91 and way above its 52-week low of $14.05.

Revenue Growth

Year-on-year quarterly revenue growth grew by 13%, now sitting on 8.58B for the twelve trailing months.

Leave a Reply

Your email address will not be published. Required fields are marked *